BD1.AX - BARD1 Life Sciences Limited

ASX - ASX Delayed price. Currency in AUD
Currency in AUD

Valuation measures

Market cap (intra-day) 546.48M
Enterprise value 338.93M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)81.41
Price/book (mrq)5.67
Enterprise value/revenue 368.18
Enterprise value/EBITDA 6N/A

Trading information

Stock price history

Beta (5Y monthly) -5.01
52-week change 349.06%
S&P500 52-week change 323.16%
52-week high 30.0560
52-week low 30.0139
50-day moving average 30.0325
200-day moving average 30.0349

Share statistics

Avg vol (3-month) 33.92M
Avg vol (10-day) 31.31M
Shares outstanding 51.37B
Float 869.83M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 311 Sep 2008

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2019
Most-recent quarter (mrq)30 Jun 2019

Profitability

Profit margin 0.00%
Operating margin (ttm)-303.20%

Management effectiveness

Return on assets (ttm)-23.83%
Return on equity (ttm)-41.55%

Income statement

Revenue (ttm)570.99k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)129.20%
Gross profit (ttm)-142.78k
EBITDA N/A
Net income avi to common (ttm)-1.72M
Diluted EPS (ttm)-0.0010
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.56M
Total cash per share (mrq)0.01
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)16.47
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-1.57M
Levered free cash flow (ttm)-928.83k